- $25.99bn
- $30.75bn
- $5.68bn
- 97
- 28
- 53
- 63
Annual balance sheet for Equifax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,685 | 225 | 285 | 217 | 170 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 631 | 728 | 858 | 908 | 958 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,478 | 1,121 | 1,371 | 1,356 | 1,361 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,139 | 1,316 | 1,587 | 1,834 | 1,892 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 9,612 | 11,041 | 11,548 | 12,280 | 11,759 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,483 | 2,291 | 2,015 | 2,019 | 1,812 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,443 | 7,457 | 7,591 | 7,746 | 6,963 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 3,168 | 3,584 | 3,957 | 4,534 | 4,797 |
| Total Liabilities & Shareholders' Equity | 9,612 | 11,041 | 11,548 | 12,280 | 11,759 |
| Total Common Shares Outstanding |